Hantz Financial Services, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Hantz Financial Services, Inc.

  • $6.6 Billion
  • Q3 2025

A detailed history of Hantz Financial Services, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 178 shares of REGN stock, worth $123,443. This represents 0.0% of its overall portfolio holdings.

Number of Shares
178
Previous 108 64.81%
Holding current value
$123,443
Previous $57,000 75.44%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025
BUY
$534.91 - $598.71 $37,443 - $41,909
70 Added 64.81%
178 $100,000
Q2 2025

Aug 04, 2025
BUY
$483.07 - $625.6 $21,255 - $27,526
44 Added 68.75%
108 $57,000
Q1 2025

May 12, 2025
SELL
$634.14 - $744.83 $5,707 - $6,703
-9 Reduced 12.33%
64 $41,000
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $34,819 - $40,859
34 Added 87.18%
73 $77,000
Q2 2024

Jul 30, 2024
BUY
$883.2 - $1071.19 $34,444 - $41,776
39 New
39 $41,000
Q3 2023

Aug 06, 2024
SELL
$692.45 - $844.37 $15,926 - $19,420
-23 Reduced 40.35%
34 $28,000
Q2 2023

Aug 06, 2024
SELL
$700.03 - $830.35 $23,100 - $27,401
-33 Reduced 36.67%
57 $41,000
Q4 2022

Aug 06, 2024
SELL
$705.89 - $766.39 $21,882 - $23,758
-31 Reduced 25.62%
90 $65,000
Q3 2022

Aug 06, 2024
SELL
$573.97 - $724.32 $6,887 - $8,691
-12 Reduced 9.02%
121 $83,000
Q2 2022

Aug 06, 2024
SELL
$548.35 - $738.84 $16,450 - $22,165
-30 Reduced 18.4%
133 $79,000
Q1 2022

Aug 06, 2024
SELL
$595.12 - $698.43 $111,882 - $131,304
-188 Reduced 53.56%
163 $114,000
Q4 2021

Aug 06, 2024
BUY
$543.48 - $670.97 $75,543 - $93,264
139 Added 65.57%
351 $222,000
Q3 2021

Aug 06, 2024
SELL
$574.03 - $680.96 $1,722 - $2,042
-3 Reduced 1.4%
212 $128,000
Q2 2021

Aug 06, 2024
SELL
$472.8 - $558.54 $39,715 - $46,917
-84 Reduced 28.09%
215 $120,000
Q1 2021

Aug 06, 2024
BUY
$446.73 - $548.2 $116,149 - $142,532
260 Added 666.67%
299 $141,000
Q4 2020

Aug 06, 2024
BUY
$478.3 - $607.98 $371,639 - $472,400
777 Added 3.17%
25,260 $12.2 Million
Q3 2020

Aug 06, 2024
BUY
$544.75 - $658.21 $618,836 - $747,726
1,136 Added 4.87%
24,483 $13.7 Million
Q2 2020

Aug 06, 2024
BUY
$493.32 - $643.92 $554,985 - $724,410
1,125 Added 5.06%
23,347 $14.6 Million
Q1 2020

Aug 06, 2024
BUY
$336.18 - $494.43 $7.46 Million - $11 Million
22,183 Added 56879.49%
22,222 $10.9 Million

Others Institutions Holding REGN

# of Institutions
1,490
Shares Held
86.4M
Call Options Held
2.38M
Put Options Held
1.61M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email